MYCN anticorps (C-Term)
Aperçu rapide pour MYCN anticorps (C-Term) (ABIN453206)
Antigène
Voir toutes MYCN AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody reacts to MYCN.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human MYCN
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MYCN (N-Myc Proto-Oncogene Protein (MYCN))
-
Autre désignation
- MYCN
-
Sujet
- MYCN is a member of the MYC family and a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of its gene is associated with a variety of tumors, most notably neuroblastomas.Synonyms: Class E basic helix-loop-helix protein 37, N-myc proto-oncogene protein, NMYC
-
ID gène
- 4613
-
NCBI Accession
- NP_005369
-
UniProt
- P04198
Antigène
-